You are here: Industry Insights > SARS-CoV-2

News List

Agena Bioscience Granted EUA for High-Throughput SARS-CoV-2 Panel americanpharmaceuticalreview
November 05, 2020
Agena Bioscience® announced its MassARRAY® SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Authorization from the U.S. Food and Drug Administration (FDA).
Highly potent nanoparticle COVID-19 vaccine designed using computer europeanpharmaceuticalreview
November 05, 2020
Developers suggest that the potency, stability and manufacturability of the nanoparticle vaccine candidate could enable vaccination against COVID-19 on a global scale.
Ultrapotent COVID-19 vaccine candidate designed via computer worldpharmanews
November 04, 2020
An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections.
New drug candidate for the treatment of COVID-19 worldpharmanews
November 02, 2020
Researchers from the University of Kent, the Goethe-University in Frankfurt am Main (Germany), and the Hannover Medical School (Germany) have identified a drug with the potential to provide a treatment for COVID-19.
Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel prnewswire
October 29, 2020
Agena Bioscience® announced that its MassARRAY® SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Authorization from the U.S. Food and Drug Administration (FDA).
Kroger Health Launches COVID-19 Rapid Antibody Testing at Pharmacy Locations prnewswire
October 29, 2020
Kroger Health, the healthcare division of The Kroger Co., announced the launch of rapid antibody testing across its family of pharmacies, expanding the company's existing portfolio of in-clinic and at-home COVID-19 diagnostic tests ...
HiFiBiO completes first cohort of phase 1 study of SARS-CoV-2 neutralising antibody pharmaceutical-business-review
October 29, 2020
HiFiBiO Therapeutics announced the successful completion of the first cohort of the Phase I study (NCT04590430) of HFB30132A, a SARS-CoV-2 neutralizing antibody for the treatment and prevention of COVID-19.
Clinical trials to study AstraZeneca’s COVID-19 vaccine resume globally europeanpharmaceuticalreview
October 29, 2020
Clinical trials for AZD1222, the AstraZeneca COVID-19 vaccine candidate, have resumed across the world after confirmation it is safe to do so.
Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData expresspharma
October 29, 2020
Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael Breen, Director of Infectious Diseases and Ophthalmology at GlobalData offers his view.
Beyond Air to Initiate Nitric Oxide, LungFit Study for Acute Viral Pneumonia, COVID-19 americanpharmaceuticalreview
October 28, 2020
Beyond Air announced it plans to initiate a clinical study of the LungFit™ system for evaluation of the safety and efficacy of high concentration inhaled NO given intermittently to adults hospitalized with acute viral pneumonia, including SARS-CoV-2.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page